Northern Technologies (NTIC) Q3 2026 earnings review
Record Sales Demolished by Crashing Margins
Northern Technologies achieved record Q3 revenues of $24.2M (+12.6% YoY), but the top-line success is a facade masking deep profitability issues. Management's repeated promises of 'operating leverage' and 'sequential gross margin improvement' have completely derailed. Gross margin collapsed by 477 basis points YoY to 33.6%, dragging the company into a net loss of $263K. While the ZERUST Oil & Gas segment continues its explosive growth, macroeconomic shocks from the Middle East and severe competitive pricing in the Natur-Tec segment have wiped out the bottom line. The company's balance sheet is deteriorating, directly contradicting management's prior pledges to reduce debt.
🐂 Bull Case
ZERUST Oil & Gas is accelerating, posting 72.3% YoY growth to reach a record $2.2M for Q3. The multi-year investments in global sales infrastructure and large offshore contracts in Brazil are driving real volume.
After quarters of macro-driven sluggishness in Europe, JV operating income flipped to positive growth, up 12.2% to $2.55M. This highly profitable income stream is essential for offsetting domestic losses.
🐻 Bear Case
A 477 bps drop in gross margin reveals the company's severe vulnerability to raw material cost spikes and its lack of pricing power in the Natur-Tec bioplastics segment.
Despite management explicitly citing debt reduction as a 'strategic focus' in H1, the credit line and term loan balance surged to $14.78M from $12.19M at the end of FY25. They are now selling a facility just to raise $1.15M in cash.
⚖️ Verdict: 🔴
Bearish. Top-line beats are meaningless if they destroy profitability. Management has lost credibility regarding gross margin stabilization and debt reduction. Until raw material costs structurally normalize and pricing power returns, the revenue growth is hollow.
Key Themes
Macro Geopolitics Crush Cost of Goods Sold
Management directly blamed disruptions in the Middle East and the Strait of Hormuz for spiking the cost of key raw materials (polyethylene). This external macro shock broke the narrative from Q1/Q2, where leadership claimed margin pressures were a 'temporary supplier lead time issue.' The exposure to volatile global commodity pricing remains a severe, unpredictable headwind.
The Debt Narrative Contradiction
In Q1 and Q2, the CFO firmly established that using operating leverage to pay down debt was the primary strategic focus. However, the data directly contradicts this positive narrative. The outstanding line of credit and current term loan balance expanded to $14.78M, up from $12.19M at the end of FY25. The company is burning cash and is now relying on the sale of its Beachwood, Ohio facility in FY27 to generate >$1.0M in liquidity.
China Growth Engine Abruptly Stalls
Reversing its previous trend as a star performer, NTIC China net sales slightly declined to $4.48M from $4.51M YoY. Throughout H1, management heavily touted China's domestic consumption as a tariff-immune growth engine (growing 18-23% YoY). This sudden stagnation removes a critical pillar of the company's geographic diversification strategy.
Natur-Tec Pricing Power Evaporates
While Natur-Tec sales hit a record $6.07M (up 5% YoY), the growth came at a steep cost. Management explicitly cited 'competitive pricing pressure' as a core reason for the gross margin collapse. The bioplastics market remains highly commoditized, forcing NTIC to sacrifice margins to win bids, weakening the segment's viability as a profit driver.
ZERUST Oil & Gas Hits Hypergrowth
Accelerating sequentially, ZERUST Oil & Gas sales surged 72.3% YoY to $2.2M. This validates the multi-year OpEx investments in global sales teams and the large ~$13M offshore FPSO contract in Brazil. This segment is decisively transitioning from a 'lumpy' project business into a consistent, high-growth revenue stream.
Industrial Segment Remains Resilient
The core legacy business, ZERUST Industrial, remains stable and strong, growing 10.3% YoY to a record $15.93M. As the company's largest segment (65.8% of total revenue), its steady performance provides a much-needed baseline while other segments experience extreme volatility.
Joint Venture Earnings Rebound
Accelerating after multiple quarters of macroeconomic drag in Europe, Joint Venture operating income grew 12.2% YoY to $2.55M. Total JV sales increased 15.1% to $26.7M. Given NTIC's thin consolidated margins, these high-margin equity earnings are crucial for keeping the company afloat.
Other KPIs
Reversing into the red from an adjusted net income of $228,000 a year ago. Even after adding back amortization, the core operations are currently cash-negative due to the gross margin squeeze.
Improving. OpEx decreased as a percentage of sales from 44.9% YoY. The company is effectively controlling absolute expense growth (up only 5.3%), proving that the path to profitability strictly relies on fixing gross margins, not cutting OpEx.
Guidance
Management expects pricing and procurement initiatives, combined with easing raw material costs, to improve gross margin and profitability in Q4. However, they failed to provide specific quantitative targets, limiting investor confidence after consecutive quarters of margin misses.
The company received a non-binding letter of intent to sell its Beachwood, Ohio facility for $1.15M. While this provides a small liquidity injection, the fact that a core industrial company needs to liquidate real estate to shore up 'financial flexibility' is concerning.
Key Questions
Margin Recovery Timeline
You've cited 'easing raw material costs' heading into Q4. Can you quantify the expected gross margin recovery, and how much of the Q3 compression is structurally permanent versus temporary?
Debt Reduction Reality
In H1, you stated debt reduction was a primary strategic focus, yet debt grew significantly in Q3 and cash is flat. At what point will operating cash flow actually outpace the working capital requirements of your growing revenue?
China's Sudden Stagnation
NTIC China grew roughly 20% in H1 but was flat in Q3. Is this a macro-driven domestic slowdown in China, or are you losing market share to local competitors?
Natur-Tec Viability
With competitive pricing pressure severely impacting Natur-Tec margins, are you reconsidering the investment scale in this segment, or do you have a path to introduce higher-margin, proprietary resin blends in the near term?